Minimize Risks with Plastics

Marcela Villegas

BASF
KT/KC – E100, DE-67056 Ludwigshafen, Germany
Tel: +49 621 60 42223   Fax: +49 621 60 49497
Email: marcela.villegas@basf.com

Biography

Graduated in Industrial Engineering from the University of Regina, Canada and made a specialization on Polymers from Instituto del Plastico, Mexico.

After working 3 years in BASF Mexico as Product Manager, she moved to Ludwigshafen to become Export Manager and Market Developer for Luran at BASF Germany.  She joined the Healthcare & Diagnostics Team as a Market Development Manager in November 2007.

Company Profile

BASF is the world’s leading chemical company: The Chemical Company. Its portfolio ranges from oil and gas to chemicals, plastics, performance products, agricultural products and fine chemicals. As a reliable partner BASF helps its customers in virtually all industries to be more successful. With its high-value products and intelligent solutions, BASF plays an important role in finding answers to global challenges such as climate protection, energy efficiency, nutrition and mobility. BASF produces a series of plastics for applications in the “Healthcare and Diagnostics” sector and has set up a team to respond to market demands. BASF has about 95,000 employees and posted sales of almost €58 billion in 2007. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN). www.basf.com.

Abstract

Plastics belong to the most flexible materials of modern times and the healthcare and diagnostics (HD) industry is one of the most important and advanced industries these materials are employed in; mistakes are not allowed.

Being highly regulated and having development processes of several years, the requirements of the healthcare and diagnostics market are especially high. Plastics suppliers who want to successfully serve this market must guarantee their customers a constant product quality, the performance of basic suitability tests and long term supply. These services can be combined in a high-performance property profile that additionally represents, among other things, the intention not to change the formulation in the long term and that offers different advantages for the customer such as reduced testing and approval efforts and safe planning.

Product safety is not only guaranteed through various preliminary compatibility tests, but the HD grades moreover meet important European and American requirements and a Drug Master File is compiled for all products.

The HD product portfolio includes:

1. Terlux® 2802 and 2812 HD, transparent MABS grades combining the advantages of ABS and PMMA,
2. Terluran® HD-15, an ABS especially standing out for its improved chemical resistance,
3. Luran® HD, a SAN type having the decisive advantage of a particularly low level of inherent color and thus an outstanding clarity and last but not least
4. Ultraform® S2320 003 PRO and Ultraform® W2320 003 PRO, both semicrystalline materials that withstand mechanical stress very well and moreover the first engineering plastics in the HD family optimized for applications in medical technology.